Short-acting GLP-1RAs exhibit a considerable fluctuation in circulating levels during the daytime that, in turn, produce an intermittent activation of GLP-1R, resulting in different pharmacodynamic effects compared to long-acting GLP-1RA (66)
There is limited data on semaglutide and birth defects in humans, but animal studies have shown some risk to fetal development
Some studies suggest that the beneficial effects of GLP-1RAs can be dampened by the deleterious effects of long-standing T2DM resulting in the reduced capacity to secrete insulin and diminished incretin effects, resulting in reduced glucose-lowering efficacy of GLP-1RA [89, 90]
IGF-1 LR3 has been used extensively in this context precisely because its extended half-life allows sustained receptor activation in cell culture and in vivo models without the impractical dosing frequency that native IGF-1 would require
The process was straightforward, and I received my prescription quickly, he noted
This is good news for telehealth access